AHR and neoplasm: The latter serves as a ligand to activate the transcription factor AHR, which may enhance tumor progression by promoting cancer cell movement (Sadik et al., 2020), inhibiting T-cells activation and proliferation (Boulland et al., 2007), and regulating the development and function of B-cells (Aubatin et al., 2018).